← Leaderboards
Andrew J Vickers
Sloan-Kettering Institute For Cancer Res
$4,651,618
Attributed
$7,302,336
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–18$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,302,336 · 7
By mechanism
R01$5,819,919 · 3
R21$1,357,175 · 3
P30$125,242 · 1
Top collaborators
- Donna Pauler Ankerst5 shared
- Stephen Boorjian4 shared
- Matthew R Cooperberg4 shared
- Richard Bernard Hayes4 shared
- Hans GãSta Lilja4 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Arti Hurria$7,678,132
- Ariela Noy$497,605
- William L Gerald$10,319,111
- Kristen L Zakian$1,011,534
- Philip O. Livingston$8,464,484
Others in their field
Top investigators on “Randomized”
- James Dennis Neaton · Northwestern University$305,243,252
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$292,521,996
- Lawrence Corey · Fred Hutchinson Cancer Center$292,521,996
- Marian Ewell · The Emmes Company, Llc$278,931,253
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$199,647,509
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
Research focus
RandomizedCharacteristicsCollaborationsGrantResearch PersonnelMalignant NeoplasmsInternationalSpecific Qualifier ValueMalignant Neoplasm Of ProstateUpdatePublicationsSiteBack PainEffectivenessClinical AssessmentsChronic PainEuropeMeta-AnalysisData AnalysesData SetBloodDatabasesAffectBiopsy
Grant awards (22)
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome$453,825
R01 · FY2018 · CA · contact PI
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome$442,771
R01 · FY2017 · CA · contact PI
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome$442,771
R01 · FY2016 · CA · contact PI
Prospective validation of a multi-marker prostate cancer prediction model$464,784
R01 · FY2015 · CA
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome$445,807
R01 · FY2015 · CA · contact PI
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$304,293
R01 · FY2015 · AT · contact PI
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome$549,718
R01 · FY2014 · CA · contact PI
Prospective validation of a multi-marker prostate cancer prediction model$452,928
R01 · FY2014 · CA
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$347,764
R01 · FY2014 · AT · contact PI
Web Survey Core$125,242
P30 · FY2014 · CA · contact PI
Prospective validation of a multi-marker prostate cancer prediction model$463,618
R01 · FY2013 · CA
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$304,294
R01 · FY2013 · AT · contact PI
Prospective validation of a multi-marker prostate cancer prediction model$472,760
R01 · FY2012 · CA
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$358,521
R01 · FY2012 · AT · contact PI
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$316,065
R01 · FY2011 · AT · contact PI
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$231,413
R21 · FY2010 · AT · contact PI
Clinically-Integrated Randomized Trial of Radical Prostatectomy$255,960
R21 · FY2009 · CA · contact PI
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$187,000
R21 · FY2009 · AT · contact PI
Clinically-Integrated Randomized Trial of Radical Prostatectomy$329,392
R21 · FY2008 · CA · contact PI
Acupuncture Trialists' Collaboration: meta-analysis of chronic pain trials$185,260
R21 · FY2008 · AT · contact PI
Methodology of Phase I and II trials of anticancer CAM$84,250
R21 · FY2004 · CA
Methodology of Phase I and II trials of anticancer CAM$83,900
R21 · FY2003 · CA